BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Campbell CM, Cassol C, Cataland SR, Kahwash R. Atypical haemolytic uraemic syndrome: a case report of a rare cause of reversible cardiomyopathy. Eur Heart J Case Rep 2020;4:1-6. [PMID: 32352052 DOI: 10.1093/ehjcr/ytaa050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ali MAM, Spinler SA. COVID-19 and thrombosis: From bench to bedside. Trends Cardiovasc Med 2021;31:143-60. [PMID: 33338635 DOI: 10.1016/j.tcm.2020.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
2 Campbell CM, Kahwash R. Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis? Circulation 2020;141:1739-41. [DOI: 10.1161/circulationaha.120.047419] [Cited by in Crossref: 142] [Cited by in F6Publishing: 103] [Article Influence: 71.0] [Reference Citation Analysis]
3 Allegra A, Innao V, Allegra AG, Musolino C. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies. Ann Hematol 2020;99:1953-65. [PMID: 32671455 DOI: 10.1007/s00277-020-04182-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
4 Campbell CM, Guha A, Haque T, Neilan TG, Addison D. Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review. J Clin Med 2020;9:E2935. [PMID: 32932930 DOI: 10.3390/jcm9092935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]